Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Risk of Neuroleptic Malignant Syndrome.

MLA

Caroff, Stanley N., et al. “Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Risk of Neuroleptic Malignant Syndrome.” Pediatric Neurology, vol. 66, Jan. 2017, p. e3. EBSCOhost, https://doi.org/10.1016/j.pediatrneurol.2016.10.005.

APA

Caroff, S. N., Mann, S. C., & Campbell, E. C. (2017). Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Risk of Neuroleptic Malignant Syndrome. Pediatric Neurology, 66, e3. https://doi.org/10.1016/j.pediatrneurol.2016.10.005

Chicago

Caroff, Stanley N, Stephan C Mann, and E Cabrina Campbell. 2017. “Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Risk of Neuroleptic Malignant Syndrome.” Pediatric Neurology 66 (January): e3. doi:10.1016/j.pediatrneurol.2016.10.005.